Published in BMC Med on January 06, 2014
Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis | NCT04612582
Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement. Bone Marrow Transplant (2015) 0.77
Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy. Bone Marrow Transplant (2016) 0.75
The Clinical Presentation and Management of Systemic Light-Chain Amyloidosis in China. Kidney Dis (Basel) (2016) 0.75
Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis. Leukemia (2016) 0.75
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med (2005) 15.30
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med (2008) 13.06
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia (2008) 8.85
Molecular mechanisms of amyloidosis. N Engl J Med (2003) 7.75
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. Lancet Oncol (2011) 5.67
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol (2005) 5.64
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med (2004) 4.05
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol (2004) 3.43
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol (2012) 3.35
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial. Blood (2006) 2.97
Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study. Blood (2011) 2.82
Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone. Haematologica (2007) 2.44
Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. J Clin Oncol (2010) 2.20
Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study. Blood (2009) 2.19
Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis. Blood (2012) 1.88
Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival. Blood (2012) 1.80
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia (2012) 1.60
Autologous stem cell transplantation for primary systemic amyloidosis. Blood (2002) 1.58
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis. Blood (2006) 1.54
Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report. Bone Marrow Transplant (2000) 1.52
Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med (1996) 1.49
Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis. Blood (2007) 1.48
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood (1996) 1.42
Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response. Haematologica (2007) 1.40
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood (2004) 1.38
Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease. Haematologica (2008) 1.38
The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL). Blood (2004) 1.30
Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood (1999) 1.24
An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant (2001) 1.20
Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment. Am J Hematol (2013) 1.14
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. Br J Haematol (1998) 1.12
High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study. Br J Haematol (2004) 1.11
Amyloidosis. Curr Treat Options Oncol (2006) 0.99
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis. J Clin Oncol (1999) 0.99
Advances in the treatment of amyloidosis. N Engl J Med (2007) 0.96
Current treatment of AL amyloidosis. Haematologica (2009) 0.95
Transplantation vs. conventional-dose therapy for amyloidosis. Curr Opin Oncol (2011) 0.93
Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis. Leukemia (2012) 0.92
Bortezomib subcutaneous injection in combination regimens for myeloma or systemic light-chain amyloidosis: a retrospective chart review of response rates and toxicity in newly diagnosed patients. Clin Ther (2013) 0.87
Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study. Haematologica (2011) 0.85
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplant (2004) 0.84
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39
Variants of DENND1B associated with asthma in children. N Engl J Med (2009) 4.18
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet (2009) 3.19
Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol (2011) 3.05
From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes. PLoS Genet (2009) 2.99
A genome-wide association study identifies a locus for nonsyndromic cleft lip with or without cleft palate on 8q24. J Pediatr (2009) 2.44
The role of obesity-associated loci identified in genome-wide association studies in the determination of pediatric BMI. Obesity (Silver Spring) (2009) 2.34
Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nat Genet (2010) 2.30
Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature (2010) 2.21
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. Ann Intern Med (2015) 1.99
Exploratory quantum resonance spectrometer as a discriminator for psychiatric affective disorders. J Nerv Ment Dis (2014) 1.97
New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet (2012) 1.90
Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci U S A (2010) 1.85
Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet (2010) 1.81
Complete genome sequence of the complex carbohydrate-degrading marine bacterium, Saccharophagus degradans strain 2-40 T. PLoS Genet (2008) 1.64
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet (2011) 1.63
A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet (2011) 1.60
The influence of pH and organic matter content in paddy soil on heavy metal availability and their uptake by rice plants. Environ Pollut (2010) 1.58
Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2. Clin Cancer Res (2006) 1.58
Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy. Oncotarget (2014) 1.51
Surgery for marfan patients with acute type a dissection using a stented elephant trunk procedure. Ann Thorac Surg (2008) 1.49
Testosterone is associated with erectile dysfunction: a cross-sectional study in Chinese men. PLoS One (2012) 1.46
Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis. Nephrology (Carlton) (2012) 1.45
Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res (2003) 1.44
Transcriptome and targetome analysis in MIR155 expressing cells using RNA-seq. RNA (2010) 1.39
A genome-wide study reveals copy number variants exclusive to childhood obesity cases. Am J Hum Genet (2010) 1.36
The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res (2005) 1.36
Examination of type 2 diabetes loci implicates CDKAL1 as a birth weight gene. Diabetes (2009) 1.34
Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling. Cancer Res (2004) 1.33
Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol Cancer Ther (2007) 1.30
Genetic variation of HvCBF genes and their association with salinity tolerance in Tibetan annual wild barley. PLoS One (2011) 1.30
Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology (2005) 1.27
Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers. Mol Cancer Ther (2005) 1.26
Role of BMI-associated loci identified in GWAS meta-analyses in the context of common childhood obesity in European Americans. Obesity (Silver Spring) (2011) 1.21
Investigation of the locus near MC4R with childhood obesity in Americans of European and African ancestry. Obesity (Silver Spring) (2009) 1.19
The role of height-associated loci identified in genome wide association studies in the determination of pediatric stature. BMC Med Genet (2010) 1.17
End-to-end continuous manufacturing of pharmaceuticals: integrated synthesis, purification, and final dosage formation. Angew Chem Int Ed Engl (2013) 1.15
Foetal nicotine exposure causes PKCε gene repression by promoter methylation in rat hearts. Cardiovasc Res (2010) 1.14
Processive endoglucanases mediate degradation of cellulose by Saccharophagus degradans. J Bacteriol (2009) 1.14
Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol (2013) 1.12
Berberine suppresses androgen receptor signaling in prostate cancer. Mol Cancer Ther (2011) 1.11
Examination of all type 2 diabetes GWAS loci reveals HHEX-IDE as a locus influencing pediatric BMI. Diabetes (2009) 1.10
Tissue metabolic responses to salt stress in wild and cultivated barley. PLoS One (2013) 1.10
GWAS of blood cell traits identifies novel associated loci and epistatic interactions in Caucasian and African-American children. Hum Mol Genet (2012) 1.09
Direct effect of cocaine on epigenetic regulation of PKCepsilon gene repression in the fetal rat heart. J Mol Cell Cardiol (2009) 1.09
A genome-wide association and gene-environment interaction study for serum triglycerides levels in a healthy Chinese male population. Hum Mol Genet (2011) 1.06
Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans. Cancer Epidemiol Biomarkers Prev (2012) 1.06
Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res (2014) 1.05
Endoplasmic reticulum stress signal mediators are targets of selenium action. Cancer Res (2005) 1.05
The rice narrow leaf2 and narrow leaf3 loci encode WUSCHEL-related homeobox 3A (OsWOX3A) and function in leaf, spikelet, tiller and lateral root development. New Phytol (2013) 1.04
Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder. PLoS One (2010) 1.04
Chronic hypoxia during gestation causes epigenetic repression of the estrogen receptor-α gene in ovine uterine arteries via heightened promoter methylation. Hypertension (2012) 1.03
Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrol Dial Transplant (2010) 1.02
AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression. Diagn Pathol (2014) 1.01
Enhanced and switchable nanoscale thermal conduction due to van der Waals interfaces. Nat Nanotechnol (2011) 1.00
Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer. PLoS One (2012) 1.00
Long-term efficacy of tonsillectomy in Chinese patients with IgA nephropathy. Am J Nephrol (2007) 1.00
Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability. PLoS One (2011) 0.99
Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo. Biochem Pharmacol (2012) 0.99
Prenatal cocaine exposure abolished ischemic preconditioning-induced protection in adult male rat hearts: role of PKCepsilon. Am J Physiol Heart Circ Physiol (2009) 0.98
Significance of histological crescent formation in patients with diffuse proliferative lupus nephritis. Am J Nephrol (2013) 0.98
Kruppel-like factor 4 is a novel mediator of selenium in growth inhibition. Mol Cancer Res (2008) 0.98
Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival. Anticancer Res (2010) 0.98
Structural determinants of an insect beta-N-Acetyl-D-hexosaminidase specialized as a chitinolytic enzyme. J Biol Chem (2010) 0.98
Clinical and morphological features of fibronectin glomerulopathy: a report of ten patients from a single institution. Clin Nephrol (2015) 0.97
Genome-wide association study for serum complement C3 and C4 levels in healthy Chinese subjects. PLoS Genet (2012) 0.97
Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancer. Int J Cancer (2013) 0.95
20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor. Int J Cancer (2012) 0.95
Carbohydrase systems of Saccharophagus degradans degrading marine complex polysaccharides. Mar Drugs (2011) 0.95
Three flavonoids targeting the beta-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: crystal structure characterization with enzymatic inhibition assay. Protein Sci (2008) 0.94
Telomerase as an important target of androgen signaling blockade for prostate cancer treatment. Mol Cancer Ther (2010) 0.93
Removal of neutrophil gelatinase-associated lipocalin by extracorporeal therapies. Hemodial Int (2009) 0.92
Optimized circularly symmetric phase mask to extend the depth of focus. J Opt Soc Am A Opt Image Sci Vis (2009) 0.92
Quantitative trait loci associated with functional stay-green SNU-SG1 in rice. Mol Cells (2007) 0.89
Cold-inducible RNA binding protein inhibits H₂O₂-induced apoptosis in rat cortical neurons. Brain Res (2012) 0.89
Effects of mycophenolate mofetil for patients with crescentic lupus nephritis. Nephrology (Carlton) (2008) 0.89
Pathological demography of native patients in a nephrology center in China. Chin Med J (Engl) (2003) 0.89
Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro. Arch Toxicol (2006) 0.89
Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection. J Am Soc Nephrol (2011) 0.89
Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies. J Pathol (2014) 0.89
Clinical evaluation of two different extracorporeal membrane oxygenation systems: a single center report. Artif Organs (2011) 0.88
BMD-associated variation at the Osterix locus is correlated with childhood obesity in females. Obesity (Silver Spring) (2011) 0.88
Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance. Biomaterials (2010) 0.88
Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial. J Transl Med (2013) 0.88
The molecular mechanisms that underlie the tumor suppressor function of LKB1. Acta Biochim Biophys Sin (Shanghai) (2009) 0.87
Rhein protects pancreatic β-cells from dynamin-related protein-1-mediated mitochondrial fission and cell apoptosis under hyperglycemia. Diabetes (2013) 0.87
Central corneal thickness and glaucoma in adult Chinese: the Beijing Eye Study. J Glaucoma (2008) 0.87
Thiophenic compounds adsorption on Na(I)Y and rare earth exchanged Y zeolites: a density functional theory study. J Mol Model (2013) 0.87
Genetic evidence for an interaction of the UbiG O-methyltransferase with UbiX in Escherichia coli coenzyme Q biosynthesis. J Bacteriol (2006) 0.86
Continuous veno venous hemofiltration in treatment of acute necrotizing pancreatitis. Chin Med J (Engl) (2003) 0.86